For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Midazolam (Benzodiazepine (short-acting)) – indications: Conscious sedation (procedures), Induction of anaesthesia (adults < 60 y, premedicated), Sedation of ventilated patients (intensive care/transport), Status epilepticus – adults, without i.v. access, Status epilepticus – children. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Conscious sedation (procedures)
- Induction of anaesthesia (adults < 60 y, premedicated)
- Sedation of ventilated patients (intensive care/transport)
- Status epilepticus – adults, without i.v. access
- Status epilepticus – children
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Rosenow F, Weber J et al. S2k-Leitlinie Status epilepticus im Erwachsenenalter. Deutsche Gesellschaft für Neurologie gemeinsam mit der Österreichischen Gesellschaft für Neurologie (ÖGN), 2020; AWMF-Register 030-079, korrigierte Registerfassung 03/2022, gültig bis 29.06.2025.
- Trollmann R, Brandl U et al. (Gesellschaft für Neuropädiatrie). S1-Leitlinie Therapie des konvulsiven Status epilepticus im Kindes- und Jugendalter (jenseits der Neugeborenenperiode). AWMF-Register 022-019 (Fassung 2025; Recherche nennt auch Stand 01/2026.
- Resuscitation Council UK. Paediatric emergency algorithms and resources, Version 6, 02/2026.
- Resuscitation Council UK. Paediatric advanced life support algorithm.
- Summaries of product characteristics of authorised products – product and section for each dose in the app.